Brief: Cingulate Receives Guidance From FDA On Path Forward For Anxiety Asset Ctx-2103 (Buspirone)

Cingulate

01/12/2023 14:12

Cingulate Inc  CING.O :
    * CINGULATE RECEIVES GUIDANCE FROM FDA ON PATH FORWARD FOR
ANXIETY
ASSET CTX-2103 (BUSPIRONE)
    * CINGULATE INC - RECEIVED INPUT FROM FDA REGARDING
REGULATORY
PATHWAY FOR CTX-2103, INCLUDING FILING IND APPLICATION IN FIRST
HALF OF 2024

Source text for Eikon:  ID:nGNX2TTrGF 
Further company coverage:  CING.O